Table 1.
Patient's follow-up: vital signs, GCS, and laboratory investigations, which reflect the improvement in her situation
| Day 0 | Day 3 | Day 4 (the first day in our hospital) | Day 5 | Day 7 | Day 10 (the day of discharge) | Day 180 (follow-up) | |
|---|---|---|---|---|---|---|---|
| Vital signs | Stable | Unstable | Stable | Stable | Stable | ||
| Hepatic encephalopathy grade | 4 | 4 | 4 | ||||
| GCS | 8 | 3 | 15 | 15 | |||
| HB, g/dL | 10.5 | 11.1 | |||||
| TWBCS, ×103 | 10.4 | 8.1 | 11.3 | 8.8 | 10.4 | 7.2 | 5.6 |
| Platelets, ×109 | 272 | ||||||
| Total bilirubin, mg/dL | 10.5 | 12.9 | 14.6 | 14.4 | 13.1 | 13 | 1.5 |
| Direct bilirubin, mg/dL | 7 | 8.3 | 9.9 | 9.1 | 9 | 7.3 | 0.99 |
| ALT, U/L | 2173 | 617 | 489 | 376 | 254 | 100 | 29 |
| AST, U/L | 938 | 160 | 154 | 153 | 153 | 86 | 25 |
| PT, % | <4 | 14 | 22 | 18 | 22 | 46 | |
| INR | 7.1 | 3.9 | 3.3 | 3.7 | 3.4 | 1.7 | 1 |
| Blood glucose, mg/dL | 98 | ||||||
| BUN, mg/dL | 13 | 14 | 8 | 11 | 8 | 10 | |
| Serum creatinine, mg/dL | 0.6 | 0.4 | 0.4 | 0.8 | 0.4 | 0.7 | |
| Serum sodium, mg/dL | 141 | 143 | 136 | 135 | 136 | 138 | |
| Serum potassium, mg/dL | 3.4 | 3.6 | 4.2 | 5 | 3.6 | 3.4 | |
| Ca+, mg/dL | 0.95 | 6.6 | |||||
| ICT for malaria | Negative | ||||||
| Anti-HAV IgM | Positive (6.7) | ||||||
| Anti-HCV IgM | Negative | ||||||
| AgHBs | Negative | ||||||
| Serum albumin, g/dL | 106 | 84 | 70 | 67 |
GCS, Glasgow Coma Scale; AST, aspartate transaminase; ALT, alanine aminotransferase; HAV, hepatitis A virus; INR, international normalized ratio.